Process View
Any process that activates or increases the frequency, rate or extent of B cell activation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of b cell activation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BCL2 | B-cell CLL/lymphoma 2 | 0.985 | ||
| BCL2L1 | BCL2-like 1 | 0.962 | Human | |
| IL4R | interleukin 4 receptor | 0.895 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.706 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.301 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.247 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.220 | ||
| BAX | BCL2-associated X protein | 0.168 | Human | |
| GRAP2 | GRB2-related adaptor protein 2 | 0.157 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.157 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.143 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.076 | Mouse | |
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.068 | ||
| BAD | BCL2-associated agonist of cell death | 0.068 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.065 | Mouse | |
| IRAK1 | interleukin-1 receptor-associated kinase 1 | 0.061 | ||
| IL4 | interleukin 4 | 0.060 | Mouse | |
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.060 | ||
| SYK | spleen tyrosine kinase | 0.056 | Mouse | |
| TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 0.055 | ||
| BID | BH3 interacting domain death agonist | 0.050 | ||
| LAT | linker for activation of T cells | 0.049 | ||
| CSNK1G1 | casein kinase 1, gamma 1 | 0.046 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.046 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.044 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.042 | Human | |
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.041 | ||
| IL6R | interleukin 6 receptor | 0.036 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.033 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.033 | ||
| HDAC4 | histone deacetylase 4 | 0.032 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.032 | ||
| TP53BP1 | tumor protein p53 binding protein 1 | 0.031 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.030 | Mouse | |
| IRAK4 | interleukin-1 receptor-associated kinase 4 | 0.030 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.026 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.025 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.024 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.024 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.023 | ||
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.023 | ||
| TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | 0.023 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.023 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.023 | ||
| AMBRA1 | autophagy/beclin-1 regulator 1 | 0.022 | ||
| GAS7 | growth arrest-specific 7 | 0.021 | ||
| MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.021 | ||
| STK11 | serine/threonine kinase 11 | 0.020 | ||
| DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.020 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.020 | ||
| ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.020 | ||
| SLA | Src-like-adaptor | 0.020 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.019 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.019 | ||
| IL2RB | interleukin 2 receptor, beta | 0.018 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.018 | ||
| DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 0.018 | ||
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.018 | ||
| PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 | 0.018 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.017 | ||
| FERMT2 | fermitin family member 2 | 0.017 | ||
| BLNK | B-cell linker | 0.017 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.017 | ||
| PCDH9 | protocadherin 9 | 0.017 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.016 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.016 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.016 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.016 | ||
| EP300 | E1A binding protein p300 | 0.016 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.015 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.015 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.015 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.015 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.015 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.014 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.013 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.013 | ||
| RNF144B | ring finger protein 144B | 0.013 | ||
| PIK3CG | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 0.013 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.013 | ||
| FOXO1 | forkhead box O1 | 0.013 | ||
| TCF12 | transcription factor 12 | 0.012 | Human | |
| NCOA2 | nuclear receptor coactivator 2 | 0.012 | ||
| JAK3 | Janus kinase 3 | 0.012 | ||
| ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 0.012 | ||
| BCL2A1 | BCL2-related protein A1 | 0.012 | ||
| LY96 | lymphocyte antigen 96 | 0.012 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.012 | ||
| C16orf53 | chromosome 16 open reading frame 53 | 0.011 | ||
| ENG | endoglin | 0.011 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.011 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.011 | ||
| SELL | selectin L | 0.011 | ||
| CD22 | CD22 molecule | 0.011 | ||
| IL7R | interleukin 7 receptor | 0.011 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.011 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.011 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.011 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.011 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.010 | ||
| LRMP | lymphoid-restricted membrane protein | 0.010 | ||
| PYCARD | PYD and CARD domain containing | 0.010 | ||
| PTEN | phosphatase and tensin homolog | 0.010 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.010 |